The first real-world results for direct-acting antiviral (DAA) treatment of hepatitis C in Australia show efficacy rates are on par with clinical trials but almost one in seven patients are being lost to follow-up. Between March 2016 and March 2017, gastroenterologist and hepatologist Dr James Haridy and colleagues in South Australia followed up 1909 patients with ...
Australia’s experience of DAA roll out shows high efficacy
By Tessa Hoffman
20 Jun 2018